Avigan
Essam’s remarks come shortly before the European Commission announced on Friday granting conditional approval for antiviral Remdesivir for coronavirus treatment. Egypt has already started to produce the drug.
Egypt’s 23-year old drug manufacturer Eva Pharma announced starting producing antiviral <b>Remdesivir</b> as the first expected therapy for the novel coronavirus (COVID-19), Reuters reported.
This means the 112-year old university has published most of the researches on coronavirus nationwide. So far, 55 researches have been issued and 33 clinical studies have been conducted in Egypt, according to the statement.
The Presidential Advisor for Health Affairs said that there is no drug for the COVID-19, but Avigan helps patients recover fast.
